758 related articles for article (PubMed ID: 9399334)
1. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan.
Shetty SS; DelGrande D
J Pharmacol Exp Ther; 2000 Jul; 294(1):179-86. PubMed ID: 10871310
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169
[TBL] [Abstract][Full Text] [Related]
4. KT3-671, an angiotensin AT1 receptor antagonist, attenuates vascular but not cardiac responses to sympathetic nerve stimulation in pithed rats.
Takata Y; Kurihara J; Yoda T; Suzuki S; Matsuoka Y; Okubo Y; Kato H
J Cardiovasc Pharmacol; 2001 Apr; 37(4):427-36. PubMed ID: 11300656
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
7. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical data.
Brooks DP; Ohlstein EH; Ruffolo RR
Am Heart J; 1999 Sep; 138(3 Pt 2):246-51. PubMed ID: 10467220
[TBL] [Abstract][Full Text] [Related]
9. Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy?
Dendorfer A; Dominiak P; Tempel K; Raasch W
J Hypertens; 2005 Oct; 23(10):1861-7. PubMed ID: 16148610
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
11. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
[TBL] [Abstract][Full Text] [Related]
12. Effects of the AT1 antagonist HR 720 in comparison to losartan on stimulated sympathetic outflow, blood pressure, and heart rate in pithed spontaneously hypertensive rats.
Häuser W; Dendorfer A; Nguyen T; Dominiak P
Kidney Blood Press Res; 1998; 21(1):29-35. PubMed ID: 9661134
[TBL] [Abstract][Full Text] [Related]
13. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
[TBL] [Abstract][Full Text] [Related]
15. Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function.
Wong PC; Bernard R; Timmermans PB
Hypertension; 1992 Jun; 19(6 Pt 2):663-7. PubMed ID: 1592464
[TBL] [Abstract][Full Text] [Related]
16. Elevation of sympathetic activity by eprosartan in young male subjects.
Heusser K; Vitkovsky J; Raasch W; Schmieder RE; Schobel HP
Am J Hypertens; 2003 Aug; 16(8):658-64. PubMed ID: 12878372
[TBL] [Abstract][Full Text] [Related]
17. Influence of nonpeptide angiotensin II receptor antagonist, losartan, on neurogenic vasoconstriction.
Tabrizchi R
J Cardiovasc Pharmacol; 1995 May; 25(5):717-23. PubMed ID: 7630150
[TBL] [Abstract][Full Text] [Related]
18. Facilitation by procaterol, a beta-adrenoceptor agonist, of noradrenaline release in the pithed rat independently of angiotensin II formation.
Kotsonis P; Majewski H
Br J Pharmacol; 1994 Nov; 113(3):781-8. PubMed ID: 7858867
[TBL] [Abstract][Full Text] [Related]
19. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
[TBL] [Abstract][Full Text] [Related]
20. Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action.
Christophe B; Libon R; Cazaubon C; Nisato D; Manning A; Chatelain P
Eur J Pharmacol; 1995 Aug; 281(2):161-71. PubMed ID: 7589203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
